RTTNews) – Bayer announced the submission of an application to the European Medicines Agency for the oral androgen receptor inhibitor darolutamide. The company is seeking approval for the use of darolutamide in combination with androgen deprivation therapy in patients with metas…
Read More
Related Posts
Diamond Recovery Center Announces New Leadership Appointments
Diamond Recovery Center announces Tammy Titus as the new Clinical Director and Andrew Pierce as the new Outpatient Director for their addiction rehab center in […]
Radio host who interviewed Biden leaves station after admitting campaign aides gave her pre-selected questions
Radio host Andrea Lawful-Sanders has resigned from WURD Radio after admitting her post-debate interview with President Joe Biden included questions that were pre-selected by Biden’s […]
‘Inside Out 2’ launches to $13 million in previews, the most of any 2024 film
The original “Inside Out,” which hit theaters in June 2015, opened to $90.5 million domestically after $3.7 million in previews. Joy, voiced by Amy Poehler, […]